Details of the Drug Reposition

General Information of This Drug (ID: DMFBUTF)

Drug Name
BMS-986183   DMFBUTF

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Hepatocellular carcinoma DIS0J828 2C12.02 Phase 1/2 [1]
------------------------------------------------------------------------------------
1 Patented Indication(s)
Indication Name Indication ID ICD-11 Status REF
Angiogenesis disorder DISCXJBH BE2Z Patented [2]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 VEGFR-2 inhibitors and the therapeutic applications thereof: a patent review (2012-2016).Expert Opin Ther Pat. 2017 Sep;27(9):987-1004.